{
    "id": "ac306e97-8aaf-4fea-b186-1bbb20b6cd13",
    "indications": {
        "text": "zolpidem tartrate tablets indicated short-term treatment insomnia characterized difficulties sleep initiation . zolpidem tartrate tablets shown decrease sleep latency 35 days controlled [ ( 14 ) ] . trials performed support efficacy 4 5 weeks duration final formal assessments sleep latency performed end treatment .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "lowest dose effective patient must exceed total 10 mg daily ( 2.1 ) treatment short possible ( 2.1 ) recommended initial dose single dose 5 mg women single dose 5 10 mg men , immediately bedtime least 7 8 hours remaining planned time awakening ( 2.1 ) geriatric patients patients mild moderate hepatic impairment : recommended dose 5 mg men women ( 2.2 ) lower doses cns depressants may necessary taken concomitantly zolpidem tartrate tablets ( 2.3 ) effect zolpidem tartrate tablets may slowed taken immediately meal ( 2.4 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "product : 50090-3879 ndc : 50090-3879-0 20 tablet , film coated bottle ndc : 50090-3879-1 30 tablet , film coated bottle , plastic ndc : 50090-3879-3 3 tablet , film coated bottle , plastic ndc : 50090-3879-2 10 tablet , film coated bottle ndc : 50090-3879-4 60 tablet , film coated bottle",
    "adverseReactions": "zolpidem tartrate tablets contraindicated patients experienced complex sleep behaviors taking zolpidem tartrate tablets [ ( 5.1 ) ] . known hypersensitivity zolpidem . observed include anaphylaxis angioedema [ ( 5.4 ) ] .",
    "ingredients": [
        {
            "name": "ZOLPIDEM TARTRATE",
            "code": "WY6W63843K",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_10126"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "CI 77891",
            "code": "15FIX9V2JP"
        }
    ],
    "organization": "A-S Medication Solutions",
    "name": "Zolpidem Tartrate",
    "effectiveTime": "20250429",
    "indications_original": "Zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see Clinical Studies (14)].\n                  \n                  The clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment.",
    "contraindications_original": "Use the lowest dose effective for the patient and must not exceed a total of 10 mg daily (2.1) Treatment should be as short as possible ( 2.1 ) Recommended initial dose is a single dose of 5 mg for women and a single dose of 5 or 10 mg for men, immediately before bedtime with at least 7 to 8 hours remaining before the planned time of awakening (2.1) Geriatric patients and patients with mild\u00a0to moderate\u00a0hepatic impairment: Recommended dose is 5 mg for men and women (2.2) Lower doses of CNS depressants may be necessary when taken concomitantly with zolpidem tartrate tablets (2.3) The effect of zolpidem tartrate tablets may be slowed if taken with or immediately after a meal (2.4)",
    "warningsAndPrecautions_original": "Product:    50090-3879\n                  NDC:    50090-3879-0   20 TABLET, FILM COATED in a BOTTLE\n                  NDC:    50090-3879-1   30 TABLET, FILM COATED in a BOTTLE, PLASTIC \n                  NDC:    50090-3879-3   3 TABLET, FILM COATED in a BOTTLE, PLASTIC \n                  NDC:    50090-3879-2   10 TABLET, FILM COATED in a BOTTLE\n                  NDC:    50090-3879-4   60 TABLET, FILM COATED in a BOTTLE",
    "adverseReactions_original": "Zolpidem tartrate tablets are contraindicated in patients\n                  \n                     who have experienced complex sleep behaviors after taking zolpidem tartrate tablets [see Warnings and Precautions (5.1)]. \n                     \n                     with known hypersensitivity to zolpidem. Observed reactions include anaphylaxis and angioedema [see Warnings and Precautions (5.4)].",
    "drug": [
        {
            "name": "Zolpidem Tartrate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_10126"
        }
    ]
}